Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | P9 - Poster Session 9

Tuesday 04/25/23
05:30 PM - 06:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Pain
0.00 CME credit
Event Timeline
05:30 PM - 06:30 PM EST Abstract 9-001 - "The cluster before the storm": Seizure Clusters and Status Epilepticus
Clara Tierney, MD
05:30 PM - 06:30 PM EST Abstract 9-002 - SEIzure InterVAL (SEIVAL) Between Seizure Clusters and Quality of Life Across Time From a Phase 3 Safety Study of Diazepam Nasal Spray for Seizure Clusters
Sunita N. Misra, MD
05:30 PM - 06:30 PM EST Abstract 9-003 - The NORSE/FIRES Family Registry: Comparing new-onset refractory status epilepticus (NORSE) without preceding fever to febrile infection-related epilepsy syndrome (FIRES)
Karnig Kazazian
05:30 PM - 06:30 PM EST Abstract 9-004 - Epilepsia Partialis Continua Presenting as Hypoxemic Respiratory Failure
Patrick O'Connor, MD
05:30 PM - 06:30 PM EST Abstract 9-005 - Comparison of three types of Epilepsy Surgery for the treatment of Refractory Status Epilepticus: A Single Center Experience
Subhan Khan, MD
05:30 PM - 06:30 PM EST Abstract 9-006 - Knowledge and practice towards status epilepticus among emergency room physicians in the Gaza Strip: a cross-sectional study
Belal A. Aldabbour, MD
05:30 PM - 06:30 PM EST Abstract 9-007 - Modernizing Identification of Non-Convulsive Seizures and Status Epilepticus: Neurologists’ Experience at a Level 1 Trauma Center
Joshua Luster, MD
05:30 PM - 06:30 PM EST Abstract 9-008 - Dual antiglutamatergic treatment in patients with status epilepticus: a case series
Hassan Souidan, MD
05:30 PM - 06:30 PM EST Abstract 9-009 - Faster Time to Treatment of Seizure Clusters With Diazepam Nasal Spray Is Associated With Faster Cessation of Clusters and a Similar Rate of Second Dose Usage
Sunita N. Misra, MD
05:30 PM - 06:30 PM EST Abstract 9-010 - Significant Improvements in SEIzure InterVAL (Time Between Seizure Clusters) Across Time Irrespective of Age or Change in Concomitant Treatments in a Long-Term, Open-Label Safety Study of Diazepam Nasal Spray
Adrian L. Rabinowicz, MD, FAAN
05:30 PM - 06:30 PM EST Abstract 9-011 - Cushing’s Syndrome Presenting as Nonconvulsive Status Epilepticus: A Case Report and Literature Review
Kiley Cameron, MD
05:30 PM - 06:30 PM EST Abstract 9-012 - Concomitant Cannabidiol Does Not Impact Safety and Effectiveness of Diazepam Nasal Spray for Seizure Clusters: Post Hoc Analysis of a Phase 3 Safety Study
Enrique Carrazana
05:30 PM - 06:30 PM EST Abstract 15-001 - Can a Single Acute Ischemic Stroke Simulation Course Facilitate Mastery?
Casey S. Albin, MD
05:30 PM - 06:30 PM EST Abstract 15-002 - Can Self-Reported Confidence be used as an Indicator for Performance? A Multi-Center Study of Simulation Training for Acute Ischemic Stroke
Casey S. Albin, MD
05:30 PM - 06:30 PM EST Abstract 15-003 - Improving Knowledge and Diagnostic Comfort Levels through Brain Death Simulation Education
Erin Barnes, MD
05:30 PM - 06:30 PM EST Abstract 15-004 - Acute Neurological Emergencies: Using Neurology-Trained Standardized Patients To Promote Active Learning in a Case-Based Simulation Curriculum for Neurology Clerkship Students
Galina Gheihman, MD
05:30 PM - 06:30 PM EST Abstract 3-001 - Early clinical experience with cladribine tablets in a Black/Hispanic patient population
Christine Ochoa, MD
05:30 PM - 06:30 PM EST Abstract 3-002 - Postpartum Relapse Patterns Among Multiple Sclerosis Patients with Exposure to Disease Modifying Therapy Before or During Pregnancy
Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EST Abstract 3-003 - Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel Fumarate Prospective MS Pregnancy Exposure Registry
Maria K. Houtchens, MD
05:30 PM - 06:30 PM EST Abstract 3-004 - Cognitive Function During Pregnancy In Multiple Sclerosis: Is There A Decline In Processing Speed?
Juan Pablo Cuello
05:30 PM - 06:30 PM EST Abstract 3-005 - Disparities in Multiple Sclerosis Mimickers in a Diverse Population of Urban Patients
Konstantin E. Balashov, MD, PhD, FAAN
05:30 PM - 06:30 PM EST Abstract 3-007 - Implications for Age and Sex Differences on Anti-Hyperglycemic Therapy Exposure and Incidence of Newly Diagnosed Multiple Sclerosis in Propensity Score Matched Type 2 Diabetics
Gregory L. Branigan, PhD
05:30 PM - 06:30 PM EST Abstract 3-008 - Recognizing Health Disparities in Multiple Sclerosis: Experiences and Perspectives of Patients of Diverse Racial and/or Ethnic Background
Mitzi J. Williams, MD, FAAN
05:30 PM - 06:30 PM EST Abstract 3-009 - Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population
Jessica H. Fan, MD
05:30 PM - 06:30 PM EST Abstract 3-010 - African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients
Haotian Xue
05:30 PM - 06:30 PM EST Abstract 3-011 - Predictors of Conversion from Positive to Negative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Status
05:30 PM - 06:30 PM EST Abstract 3-012 - Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies
Mohammad M. Samara, MD
05:30 PM - 06:30 PM EST Abstract 3-013 - Functional Correlates of Intelligence Quotient and Cognitive Abilities Vary According to Maturation in Pediatric MS
Laura Cacciaguerra, MD, PhD
05:30 PM - 06:30 PM EST Abstract 3-014 - Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database
Riley Bove, MD, FAAN
05:30 PM - 06:30 PM EST Abstract 3-015 - Contextualizing the MS Experience for Members of the Hispanic and Latinx Community Living with MS and the Trusted MS Experts Caring for Them
Alexis Crispino
05:30 PM - 06:30 PM EST Abstract 3-016 - Patterns of Disease Modifying Therapy Utilization in Women with Multiple Sclerosis Before, During, and After Pregnancy
Anna Shah, MD
05:30 PM - 06:30 PM EST Abstract 3-017 - Threatening Illness Perception and Associated Factors in Early-stage Relapsing Remitting Multiple Sclerosis
Tamara Castillo-Trivino, MD, MAS, FAAN
05:30 PM - 06:30 PM EST Abstract 3-018 - Application of Rasch Analysis for Measurement of Disability in Multiple Sclerosis
Nadia Azad
05:30 PM - 06:30 PM EST Abstract 12-001 - Cobalamin C Deficiency, an Inborn Error of Metabolism presenting with Subacute Neuropsychiatric Symptoms
Sarah G. Engel, MD
05:30 PM - 06:30 PM EST Abstract 12-002 - Case Series of Nitrous Oxide Related Subacute Combined Degeneration from 2016 to 2022
William A. Warren, MD
05:30 PM - 06:30 PM EST Abstract 12-003 - Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship
Sofia Ramirez Guerrero
05:30 PM - 06:30 PM EST Abstract 12-004 - Just supplement Thiamine! A simple yet dramatic solution!
Bhagyashri U. Bhende, MBBS
05:30 PM - 06:30 PM EST Abstract 12-005 - Symptomatic Copper Deficiency Masquerading as Paraneoplastic Syndrome
Connor D. Welsh, DO
05:30 PM - 06:30 PM EST Abstract 12-006 - Case Report of Chronic Nitrous Oxide Abuse Presented with Cerebral Venous Thrombosis:
Samer Kebbeh, MD
05:30 PM - 06:30 PM EST Abstract 12-007 - Carcinoid Syndrome Induced B12 Deficiency Resulting in Subacute Combined Degeneration
Ravi Chilukuri, MD
05:30 PM - 06:30 PM EST Abstract 6-001 - Rise of the Biologics: Shifting Prescribing Patterns for Neurosarcoidosis
Elijah Lackey, MD
05:30 PM - 06:30 PM EST Abstract 6-002 - Neurosarcoidosis Induced by TNF-alpha Inhibitor in a Patient with Ankylosing Spondylitis
Daod Pak, MD
05:30 PM - 06:30 PM EST Abstract 6-003 - Diagnostic Relevance of the Medullary Vein Sign in Neurosarcoidosis
Shitiz K. Sriwastava, MBBS
05:30 PM - 06:30 PM EST Abstract 6-004 - Cardiac Involvement In Neurosarcoidosis: A Single Center Investigation
Sama Noroozi Gilandehi, MD
05:30 PM - 06:30 PM EST Abstract 6-005 - Neurosarcoidosis Complicated by Systemic Vasculitis
Alexander Carvajal- Gonzalez, MD, PhD
05:30 PM - 06:30 PM EST Abstract 6-006 - Rare Case of Neurosarcoidosis presenting as Isolated Longitudinal Extensive Transverse Myelitis (LETM).
Shaweta Khosa, MD
05:30 PM - 06:30 PM EST Abstract 6-007 - Tumefactive Neurosarcoidosis
Gabriela A. Bou, MD
05:30 PM - 06:30 PM EST Abstract 6-008 - A Familial Analysis of Neurosarcoidosis Utilizing the Utah Population Database
Paul D. Crane, MD
05:30 PM - 06:30 PM EST Abstract 6-009 - Tracking Motor Impairment in People with Neurosarcoidosis
Brandon P. Moss, MD
05:30 PM - 06:30 PM EST Abstract 6-010 - Neurosarcoidosis presenting as Brown-Sequard Syndrome: A Case Report
Matthias Dunse, MD
05:30 PM - 06:30 PM EST Abstract 6-011 - Seizures in Neurosarcoidosis
Henssey Ngo, MD
05:30 PM - 06:30 PM EST Abstract 6-012 - COVID-19 Outcomes in Neurosarcoidosis
Sally El Sammak, MD
05:30 PM - 06:30 PM EST Abstract 6-013 - Amyloid beta-related angiitis in a patient with light chain systemic Amyloidosis: A rare co-morbidity.
Irena Dujmovic Basuroski, MD, PhD
05:30 PM - 06:30 PM EST Abstract 6-014 - Vasculitis in the Central Nervous System: Treatment and Outcomes in a Large Single-Center Cohort
Yoji Hoshina, MD
05:30 PM - 06:30 PM EST Abstract 6-015 - Rapidly Progressive, Lethal Microangiopathy of the Brain: Two Cases of Malignant Susac Syndrome?
Shannon Tierney, MD
05:30 PM - 06:30 PM EST Abstract 6-016 - Giant Cell Arteritis with concurrent anti-MOG antibodies: Case Report
Naila Kausar, MD
05:30 PM - 06:30 PM EST Abstract 6-018 - Intracranial Pachymeningitis: A Case-Series Describing Clinical Features, Imaging, Serological and Cerebrospinal Fluid Markers, Biopsy Findings and Management
Aditi V. Varma-Doyle, MD
05:30 PM - 06:30 PM EST Abstract 6-019 - Impact of Neurological Complications on QoL in Sjögren’s Patients
Matt Makara
05:30 PM - 06:30 PM EST Abstract 6-020 - Chorea as the Initial Manifestation of Antiphospholipid Syndrome
Amaris Alayon, MD
05:30 PM - 06:30 PM EST Abstract 6-021 - Neuromuscular Disorders (Neuropathy and Myopathy) Associated with Late Onset of Stills Disease
Shaweta Khosa, MD
05:30 PM - 06:30 PM EST Abstract 6-023 - No Rheum at The Insula: Rheumatoid Lepto-meningitis as Cause of Focal Seizure
Sagi Elhassan, MD
05:30 PM - 06:30 PM EST Abstract 6-024 - A Rare Case of Rheumatoid Meningitis
Chelsea Schmoll, DO
05:30 PM - 06:30 PM EST Abstract 6-026 - Primary Antiphospholipid Syndrome Presenting with Cerebellar Stroke and Positive Titres of Anti-ß2 Glycoprotein-1 Antibody Only: A Case Report
Aditya Shah
05:30 PM - 06:30 PM EST Abstract 6-027 - Refractory Seizures in the Setting of Lupus
Azima Shaji, MD, MBBS
05:30 PM - 06:30 PM EST Abstract 6-028 - Risk of acute stroke in young patients with new-onset lupus nephritis: a case series
Danwei Wu, MD
05:30 PM - 06:30 PM EST Abstract 6-029 - The absence of antibodies in longitudinally extensive transverse myelitis and the impact on prognosis
Mirasol Forcadela, MD
05:30 PM - 06:30 PM EST Abstract 6-030 - Are Neurological Manifestations a Predictor of Poor Prognosis in Patients with Neuro-Autoimmune Disease?
Mohsen Ahmed
05:30 PM - 06:30 PM EST Abstract 6-031 - A Case of Idiopathic Immunotherapy-Responsive Autoimmune Hemichorea
Rachel Rodin, MD, PhD
05:30 PM - 06:30 PM EST Abstract 6-032 - Treatment Utilization in Dermatomyositis: An Analysis of Electronic Medical Records in the United States
Adrian Kielhorn
05:30 PM - 06:30 PM EST Abstract 7-001 - Mirror Visual Feedback as a Therapeutic Modality in Complex Regional Pain Syndrome type I - A Randomized Controlled Trial
Soroush Kakawand, MD
05:30 PM - 06:30 PM EST Abstract 7-003 - Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain In A Community Practice Setting: A Prospective Study
William D. Schnapp, MD
05:30 PM - 06:30 PM EST Abstract 7-004 - Association between Thyroid autoimmunity and Fibromyalgia: Single center retrospective study
Prasanna Venkatesan Eswaradass, MD
05:30 PM - 06:30 PM EST Abstract 7-005 - Developing Biomarkers for Chronic Low Back Pain Using Arterial Spin Labeling
Ruiyi Yuan
05:30 PM - 06:30 PM EST Abstract 7-006 - Trench Foot: Waging a War Against Pediatric Small Fiber Neuropathy
Mikael Guzman Karlsson, MD, PhD
05:30 PM - 06:30 PM EST Abstract 7-007 - Pseudo Orofacial Lingual Dyskinesia as a Manifestation of Burning Mouth Syndrome
Sunjeet Brar
05:30 PM - 06:30 PM EST Abstract 7-008 - An Iatrogenic Cause of Proximal Tibial Mononeuropathy Resulting in Undiagnosed Foot Pain
Austin J. Priaulx
05:30 PM - 06:30 PM EST Abstract 7-009 - Treatment of Medication-Resistant Neuropathic Pain in a Tetraplegic Patient Using Repetitive Transcranial Magnetic Stimulation (rTMS): A case report
Lingxuan Li
05:30 PM - 06:30 PM EST Abstract 1-001 - Pulmonary Embolism in Patients with Traumatic Brain Injury in the United States During 2016-2020
Carlos Garcia Rodriguez, MD
05:30 PM - 06:30 PM EST Abstract 1-002 - CHANTER Syndrome: Have We Been Overlooking This Catastrophic Opioid Neurotoxicity?
Muhammad I. Yousaf, MD
05:30 PM - 06:30 PM EST Abstract 1-003 - Intracranial Hypertension in Aseptic Meningitis associated with MOGAD (Myelin Oligodendrocyte Glycoprotein Antibody Disorder)
Kaitlin Schoder, NP
05:30 PM - 06:30 PM EST Abstract 1-004 - Cerebellar Hippocampal and Basal Nuclei Transient Edema with Restricted Diffusion (CHANTER): A Case Report with Literature Review
Jesse Menville
05:30 PM - 06:30 PM EST Abstract 1-005 - Erosive Squamous Cell Carcinoma of the Scalp with Dural Involvement and Subsequent Neurologic Complications
William Beaty
05:30 PM - 06:30 PM EST Abstract 1-006 - Highlighting Paradoxical Cerebral Fat Embolism: Potentially Fatal Sequela of Road Traffic Accident.
Maria Shoaib, MD
05:30 PM - 06:30 PM EST Abstract 10-001 - MxA Protein Expression and Histological Characteristics on Muscle Biopsy in Myositis
Jaya R. Trivedi, MD, FAAN
05:30 PM - 06:30 PM EST Abstract 10-002 - Handheld Muscle Ultrasound as a Tool to Assess Muscle Strength and Function in Sporadic Inclusion Body Myositis
Aliya Shabbir
05:30 PM - 06:30 PM EST Abstract 10-003 - Efficacy of Rapamycin in a Xenograft Model of Inclusion Body Myositis
Chiseko Ikenaga, MD, PhD
05:30 PM - 06:30 PM EST Abstract 10-004 - Clinical Subsets of Inclusion Body Myositis
Kenichiro Taira, MD, PhD
05:30 PM - 06:30 PM EST Abstract 10-005 - Scapular Winging In Patients With Anti-Hydroxy Methyl Glutaryl CoA Reductase (HMGCR) Antibody Positive Immune Mediated Necrotizing Myopathy (IMNM): A Case Series
Nakul Katyal, MD
05:30 PM - 06:30 PM EST Abstract 10-006 - Idiopathic Inflammatory Myopathies and Malignancy Screening: A Survey of the Current Practices Amongst Canadian Neurologists and Rheumatologists
Maria Jekielek, MD
05:30 PM - 06:30 PM EST Abstract 10-007 - Amyloid Myopathy as Initial Manifestation of ATTRwt: A Rare Phenomenon
Mario Bovino, MD
05:30 PM - 06:30 PM EST Abstract 10-008 - Cancer-associated Regional Ischemic Myopathy: A Rare Immune Myopathy
Andre Granger, MD, MBA
05:30 PM - 06:30 PM EST Abstract 10-009 - Amyloid inflammatory myopathy: report of two cases and literature review
Himanshu Gupta, MD
05:30 PM - 06:30 PM EST Abstract 10-010 - Anti-Ku myositis in clinical practice: A case series and review of the literature
Christine Meadows, MD
05:30 PM - 06:30 PM EST Abstract 10-011 - Camptocormia, a late complication of statin-associated autoimmune myopathy. (SAM)
Bhavya Narapureddy, MBBS
05:30 PM - 06:30 PM EST Abstract 10-013 - A Case of Hydroxychloroquine-Induced Neuromyopathy Causing Severe Ventilatory Failure
Paul D. Crane, MD
05:30 PM - 06:30 PM EST Abstract 10-014 - Creatine Kinase in SARS-CoV-2-Related Encephalopathy as a Prognostic Biomarker for Post-Acute Sequelae of COVID-19 (PASC)
Iqra Faiz
05:30 PM - 06:30 PM EST Abstract 10-015 - A Case of Smoldering Anti-HMGCR antibody Myopathy
Kathie Lin, MD
05:30 PM - 06:30 PM EST Abstract 4-001 - Cold Hands and Feet in Multiple System Atrophy – A Useful Diagnostic Marker?
Wolfgang Singer, MD
05:30 PM - 06:30 PM EST Abstract 4-002 - Urinary Symptom Profile in Early Multiple System Atrophy
Jessie Iregui
05:30 PM - 06:30 PM EST Abstract 4-003 - Study Design of TAK-341-2001: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-341 in Subjects With Multiple System Atrophy
Jaya Padmanabhan
05:30 PM - 06:30 PM EST Abstract 4-004 - Effect of headache on quantitative symptom scores in children and young adults with postural orthostatic tachycardia syndrome
Luke Heyliger, MD
05:30 PM - 06:30 PM EST Abstract 4-005 - Rapid Recovery of Post-Stroke Cardiovascular Autonomic Dysfunction Correlates with Neurological Improvement and Initiation of Cardiovascular Medication.
Max J. Hilz, MD, PhD, FAAN
05:30 PM - 06:30 PM EST Abstract 4-007 - Patients With Postural Orthostatic Tachycardia Syndrome Who Have Psychiatric Disorders Experience Increased Treatment Failures
Samantha J. Tidd
05:30 PM - 06:30 PM EST Abstract 4-008 - Dual Genetic Diagnoses: Phelan-McDermid Syndrome and Mitochondrial Neurogastrointestinal Encephalomyopathy
Mikael Guzman Karlsson, MD, PhD
05:30 PM - 06:30 PM EST Abstract 4-009 - A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome
Cassie N. Chan, MD
05:30 PM - 06:30 PM EST Abstract 4-010 - MEGF10 gene mutations causing a recessive congenital multiminicore myopathy
Larissa Maria F. Faria
05:30 PM - 06:30 PM EST Abstract 4-011 - Longitudinal Imaging in Kleefstra Syndrome - Case Report and Literature Review
Giovanni Castellucci, MD, MS
05:30 PM - 06:30 PM EST Abstract 4-012 - Prechtl’s General Movements performed at writhing age may help target MRI use in the NICU
Allison J. Chirigos, MD
05:30 PM - 06:30 PM EST Abstract 13-001 - Lyme Encephalomyeloradiculitis Presenting with Brachial Diplegia
Idelle V. Aschen, MD
05:30 PM - 06:30 PM EST Abstract 13-002 - Multiple Cranial Neuropathies with Orbital Myositis as an Initial Presentation of Lyme Disease
Grace Marie N. Biso, MD
05:30 PM - 06:30 PM EST Abstract 13-003 - A Perplexing Case of Borrelia Burgdorferi
Ashmeet S. Sahni, MD
05:30 PM - 06:30 PM EST Abstract 13-004 - A Case of Facial Diplegia Secondary to Lyme Neuroborreliosis
Irene Chu, MD
05:30 PM - 06:30 PM EST Abstract 13-005 - Syndrome of Inappropriate Antidiuretic Hormone Secretion - A Rare Initial Presentation of Lyme Neuroborreliosis
Satinderpal Singh, DO
05:30 PM - 06:30 PM EST Abstract 13-006 - A 74 year old man with a rash, facial droop and multifocal intracranial stenosis
Yasmin Aghajan, MD
05:30 PM - 06:30 PM EST Abstract 13-007 - Meningitis Masquerading as Migraine
Muthu Kuzhali Ganapathy, MBBS
05:30 PM - 06:30 PM EST Abstract 5-001 - Gambling Associated Risk-Taking Decision in Cerebellar Ataxia
Ruo-Yah Lai
05:30 PM - 06:30 PM EST Abstract 5-002 - The Mechanism of Disease of Tri-Nucleotide Repeat Expansion Diseases
Piet C. De Groen, MD
05:30 PM - 06:30 PM EST Abstract 5-003 - Clinical, Electroencephalographic and Neuroimage Findings of Patients with Cerebellar Ataxia and Epilepsy
Emanuel Cassou, MD
05:30 PM - 06:30 PM EST Abstract 5-004 - Spinocerebellar ataxia 21 and phenotypic variability within a single family
Mariam Hull, MD
05:30 PM - 06:30 PM EST Abstract 5-005 - Early-life social determinants of SCA6 age at onset, severity, and progression
Tiffany Chen
05:30 PM - 06:30 PM EST Abstract 5-006 - Progressive Ataxia with Palatal Tremor: A Case Series
Mattia Wruble, MD
05:30 PM - 06:30 PM EST Abstract 5-007 - Deep phenotyping in ataxia: The Massachusetts General Hospital (MGH) Ataxia Center: A three-decade retrospective
Grace Crotty, MD
05:30 PM - 06:30 PM EST Abstract 5-008 - POLG-Related Ataxia and Ophthalmoplegia: A Case Report
Taylor Peabody, MD
05:30 PM - 06:30 PM EST Abstract 5-009 - A Patient with Late-Onset Cerebellar Ataxia and a Novel FAT2 Gene Variant Concerning for Spinocerebellar Ataxia Type 45: A Case Report
Andrew N. Ameri, MD
05:30 PM - 06:30 PM EST Abstract 5-010 - Novel Mutation In The APT13A2 Gene Associated With Ataxia, Cerebellar Tremor, Bipolar Disease and Epilepsy
Muhammad I. Yousaf, MD
05:30 PM - 06:30 PM EST Abstract 5-012 - 4 mA tDCS improves walking ability in PSP: A case study
Durjoy Lahiri, MD, DM
05:30 PM - 06:30 PM EST Abstract 5-013 - OPTN: A Possible Genetic Cause of Both CBS and ALS
Matthew Feldman, MD
05:30 PM - 06:30 PM EST Abstract 5-014 - Using the iNPH Radscale as a Radiological Predictor of Clinical Outcomes after Ventriculoperitoneal Shunt Placement in Patients with Idiopathic Normal Pressure Hydrocephalus (iNPH)
Debolina Ghosh
05:30 PM - 06:30 PM EST Abstract 5-015 - Correlation of 18F-PM-PBB3 (18F-florzolotau) Tau PET Imaging with Postmortem Neuropathological Findings in A Case with Progressive Supranuclear Palsy
Hironobu Endo, MD, PhD
05:30 PM - 06:30 PM EST Abstract 5-016 - Video-oculographic Differences between Parkinson Disease and Multiple System Atrophy
Hyunji Kim
05:30 PM - 06:30 PM EST Abstract 2-001 - Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
Andrea Harriott, MD
05:30 PM - 06:30 PM EST Abstract 2-002 - A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine
Robert Croop, MD
05:30 PM - 06:30 PM EST Abstract 2-003 - Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
Shivang Joshi, MD
05:30 PM - 06:30 PM EST Abstract 2-004 - Concentration QT Interval Modeling of Intranasally Administered Zavegepant in Healthy Subjects
Jing Liu
05:30 PM - 06:30 PM EST Abstract 2-005 - Effects of Zavegepant and Concomitant Sumatriptan on Blood Pressure and Pharmacokinetics in Healthy Adult Participants
Jing Liu
05:30 PM - 06:30 PM EST Abstract 2-006 - Patterns of Medication Utilization and Migraine Frequency in Adults Using Rimegepant for Both Preventive and Acute Treatment for Migraine: Results From a 52-Week, Open-Label Extension Study
Susan Hutchinson
05:30 PM - 06:30 PM EST Abstract 2-007 - Rimegepant for the Acute and Preventive Treatment of Migraine in Women: Results From 4 Randomized, Placebo-Controlled Clinical Trials
Susan Hutchinson
05:30 PM - 06:30 PM EST Abstract 2-008 - Pharmacokinetics, Disposition, and Biotransformation of 5 mg [14C]-Zavegepant in Healthy Male Subjects After a Single Intravenous Infusion Dose
Jing Liu
05:30 PM - 06:30 PM EST Abstract 2-009 - Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials
Larry Charleston IV, MD, MSc, FAHS
05:30 PM - 06:30 PM EST Abstract 2-010 - Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population
Konstantinos Tourlas, MD
05:30 PM - 06:30 PM EST Abstract 2-011 - Effects of the Strong CYP3A4 and P-glycoprotein Inhibitor Itraconazole on the Pharmacokinetics of Oral and Intranasal Zavegepant
Jing Liu
05:30 PM - 06:30 PM EST Abstract 11-001 - A Case of Capmatinib used in MET Amplification Glioblastoma
Catherine Boldig, DO
05:30 PM - 06:30 PM EST Abstract 11-002 - Rare Dual Genotype IDH-Mutant Glioma: Two Cases of True “Oligoastrocytoma”
Isabella Sutherland
05:30 PM - 06:30 PM EST Abstract 11-003 - A Case of Infant-type Hemispheric Glioma with NTRK1 fusion
Mekka R. Garcia, MD
05:30 PM - 06:30 PM EST Abstract 11-004 - Seeing Double: a Case of a Massive Type B2 Thymoma Presenting with Pseudo-Internuclear Ophthalmoplegia
Matthew Hart, MD
05:30 PM - 06:30 PM EST Abstract 11-005 - Paraneoplastic Neurological Syndromes: A Single-Center Retrospective Study in Argentina
Francisco Caiza Zambrano
05:30 PM - 06:30 PM EST Abstract 11-006 - Progression of Multiple Myeloma Presenting as Subdural Plasmacytoma
James L. West, MD
Faculty Disclosures
No disclosure on file
James L. West, MD Dr. West has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Surgical Neurology International.
Marissa Kellogg, MD, MPH Dr. Kellogg has nothing to disclose.
Alexis Crispino Mrs. Crispino has received personal compensation for serving as an employee of Multiple Sclerosis Association of America.
John K. Evans II, DO Dr. Evans has nothing to disclose.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Danielle A. Becker, MD Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Andrea Harriott, MD Dr. Harriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Mitzi J. Williams, MD, FAAN Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to AAN interests or activities.
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Olga Carmona No disclosure on file
Sunjeet Brar Miss Brar has nothing to disclose.
Alana E. Kirby, MD, PhD The institution of Dr. Kirby has received research support from National Institutes of Health. The institution of Dr. Kirby has received research support from Cohn Family. The institution of Dr. Kirby has received research support from Postma Family.
Sara Loud Ms. Loud has received personal compensation for serving as an employee of Accelerated Cure Project, Inc. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Ms. Loud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Ms. Loud has received research support from National MS Society.
Craig Shering, Other Dr. Shering has received personal compensation for serving as an employee of AstraZeneca. An immediate family member of Dr. Shering has received personal compensation for serving as an employee of eResearch Technology Inc. Dr. Shering has stock in AstraZeneca. Dr. Shering has received intellectual property interests from a discovery or technology relating to health care.
Jaeleene Wijangco No disclosure on file
Carlos Eduardo d. Souza Filho, Jr. Mr. E Souza Filho has received research support from Universidade Federal de Minas Gerais.
Teshamae Monteith, MD, FAAN Dr. Monteith has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Global . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for e-Neura. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from Amgen. The institution of Dr. Monteith has received research support from Teva. The institution of Dr. Monteith has received research support from Electrocore. The institution of Dr. Monteith has received research support from Novartis . The institution of Dr. Monteith has received research support from Amgen. The institution of Dr. Monteith has received research support from lilly. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Massachusetts Medical Society . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Academic CME. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Education with Rockpointe. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neuodiem. Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Hope O'Brien, MD, MBA, FAAN The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GatherED . The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ms. Medicine. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Kiley Cameron, MD Dr. Cameron has nothing to disclose.
Amy Nowacki No disclosure on file
Shahd H. Hamid, MBBS Dr. Hamid has nothing to disclose.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Giovanna Manzano, MD Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Claire Miller, MD, PhD Dr. Miller has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Jessica Robinson Papp, MD, FAAN Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immgenuity Inc. Dr. Robinson Papp has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuropathix Inc. The institution of Dr. Robinson Papp has received research support from NIH. Dr. Robinson Papp has received publishing royalties from a publication relating to health care.
Joaquin A. Vizcarra, MD Dr. Vizcarra has nothing to disclose.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Stuart N. Kieran, MD No disclosure on file
Sara Pavitt, MD An immediate family member of Dr. Pavitt has received personal compensation for serving as an employee of Lundbeck.
Katrina Binkley Miss Binkley has nothing to disclose.
Claire Sonneborn No disclosure on file
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Vikram Rao, MD Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. The institution of Dr. Rao has received research support from NeuroPace, Inc.. The institution of Dr. Rao has received research support from Medtronic.
Kristen M. Krysko, MD Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Jonathan P. Hosey, MD, FAAN Dr. Hosey has nothing to disclose.
Vinay Puri, MD Dr. Puri has received personal compensation for serving as an employee of neurelis. Dr. Puri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Puri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Puri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Ruiyi Yuan Ms. Yuan has nothing to disclose.
Stavan V. Shah Mr. Shah has nothing to disclose.
Shreeja Kadakia, MD Dr. Kadakia has nothing to disclose.
Ruihao Wang, MD Dr. Wang has nothing to disclose.
Katrina Bawden, NP Ms. Bawden has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Ms. Bawden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Ms. Bawden has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Banner Life Sciences. Ms. Bawden has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG therapeutics.
Mary Donohue No disclosure on file
Lisa T. Emrick, MD Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Joshua Luster, MD Dr. Luster has nothing to disclose.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Yoji Hoshina, MD Dr. Hoshina has nothing to disclose.
Rene Andrade Machado, MD Prof. Andrade Machado has nothing to disclose.
Mona Elsayed, MD Dr. Elsayed has nothing to disclose.
Philippe-Antoine Bilodeau, MD The institution of Dr. Bilodeau has received research support from Alexion. The institution of Dr. Bilodeau has received research support from Sanofi.
Chloe Gianatasio Chloe Gianatasio has nothing to disclose.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb.
Randa G. Jarrar, MD Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
Jonathan H. Smith, MD Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Amaris Alayon, MD Ms. Alayon has nothing to disclose.
Lena Bell, MD Dr. Bell has nothing to disclose.
Pradeep Chevula, MD Dr. Chevula has nothing to disclose.
Sagi Elhassan, MD Dr. Elhassan has nothing to disclose.
Megan E. Esch, MD Dr. Esch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Esch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Esch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Esch has received research support from PCORI.
Jacqui-Lyn Saw, MD Dr. Saw has nothing to disclose.
Christopher D. Stephen, MBBS, MB ChB, FRCP, SM Dr. Stephen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Megan Vignos, PhD Dr. Vignos has stock in Biogen. Dr. Vignos has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Biogen.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Grace Marie N. Biso, MD Dr. Biso has nothing to disclose.
Leo H. Wang, MD, PhD, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Georgina Torrandell Haro Miss Torrandell Haro has nothing to disclose.
Denis T. Balaban, MD The institution of Dr. Balaban has received research support from Biogen.
Spencer Hutto, MD Dr. Hutto has nothing to disclose.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Sunil C. Naik, MD Dr. Naik has nothing to disclose.
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Belal A. Aldabbour, MD Dr. Aldabbour has nothing to disclose.
Taylor Peabody, MD Dr. Peabody has nothing to disclose.
Lingxuan Li Miss Li has nothing to disclose.
Nicholas Kemper Mr. Kemper has nothing to disclose.
Afaaq Ahmed Mr. Ahmed has nothing to disclose.
Azima Shaji, MD, MBBS Dr. Shaji has nothing to disclose.
Christopher Gomez, MD, PhD Dr. Gomez has nothing to disclose.
Anishee S. Undavia, MD Dr. Undavia has nothing to disclose.
Janice M. Rivera, MD Dr. Rivera has nothing to disclose.
Gira I. Graciano, MD Dr. Graciano has nothing to disclose.
Nagagopal Venna, MBBS, FAAN Dr. Venna has nothing to disclose.
Jonathan Weinstein, MD Dr. Weinstein has received intellectual property interests from a discovery or technology relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Devorah Segal, MD Dr. Segal has nothing to disclose.
Howard M. Chertkow, MD The institution of Dr. Chertkow has received research support from Hoffmann-La Roche Limited. The institution of Dr. Chertkow has received research support from Anavex Life Sciences. The institution of Dr. Chertkow has received research support from Alector Co.. The institution of Dr. Chertkow has received research support from Lilly.
Timothy R. Smith, MD The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Danielle S. Shpiner, MD An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from Griffin Family Foundation. The institution of Dr. Claassen has received research support from Neurocrine. The institution of Dr. Claassen has received research support from Vaccinex. The institution of Dr. Claassen has received research support from AbbVie. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche. The institution of Dr. Claassen has received research support from Prilenia. The institution of Dr. Claassen has received research support from Neurocrine/ HSG.
Wolfgang Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Bryan Paulo L. Canlas, DO Dr. Canlas has nothing to disclose.
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Erika Sigman, MD Dr. Sigman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Mustafa Al-Kharsan, MD Dr. Al-Kharsan has nothing to disclose.
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Brendan Baugher, OMS Mr. Baugher has nothing to disclose.
Toluwalase O. Tofade, MBBS Dr. Tofade has nothing to disclose.
Vishwanath Sagi, MD, FAAN Dr. Sagi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Sagi has a non-compensated relationship as a President with Commonwealth Neurological Society that is relevant to AAN interests or activities.
Chu-Yueh Guo, MD Dr. Guo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Alexander Carvajal- Gonzalez, MD, PhD Dr. Carvajal- Gonzalez has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Philippe Salles, MD Dr. Salles has nothing to disclose.
Alen Delic No disclosure on file
Justin Hoskin, MD Dr. Hoskin has nothing to disclose.
Ehizele Osehobo, MD, MSc Dr. Osehobo has nothing to disclose.
Bushra Javed, MD Dr. Javed has nothing to disclose.
Maria Campo Amigo Maria Campo Amigo has nothing to disclose.
Krista L. Eschbach, MD The institution of Dr. Eschbach has received research support from Neurocrine Biosciences. The institution of Dr. Eschbach has received research support from UCB Biopharma. The institution of Dr. Eschbach has received research support from Pediatric Epilepsy Research Foundation. Dr. Eschbach has a non-compensated relationship as a Medical Science Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Haotian Xue Mr. Xue has nothing to disclose.
Quratulain Zulfiqar Ali No disclosure on file
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Mekka R. Garcia, MD Dr. Garcia has nothing to disclose.
Himanshu Gupta, MD Dr. Gupta has nothing to disclose.
Yoonkyung Chang, MD Dr. Chang has nothing to disclose.
Ruth Dobson The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . The institution of Ruth Dobson has received research support from NMSS. The institution of Ruth Dobson has received research support from MS Society UK . The institution of Ruth Dobson has received research support from BMA Foundation . The institution of Ruth Dobson has received research support from Biogen . The institution of Ruth Dobson has received research support from Merck . The institution of Ruth Dobson has received research support from Horne Family Charitable Trust .
Mohammad M. Samara, MD Dr. Samara has nothing to disclose.
Marina AlNaser Ms. AlNaser has nothing to disclose.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Ting Zhou, MD Dr. Zhou has nothing to disclose.
Nabeel Ahmed Mr. Ahmed has nothing to disclose.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Anastasia Vishnevetsky, MD The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Kerstin Hellwig Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Ashutosh Kumar, MD Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC therapeutics. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Academy of Pediatrics. The institution of Dr. Kumar has received research support from PTC therapeutics. The institution of Dr. Kumar has received research support from Sarepta Therapeutics. The institution of Dr. Kumar has received research support from Novartis/Avexis. The institution of Dr. Kumar has received research support from Fibrogen . The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Genentech. The institution of Dr. Kumar has received research support from MDA. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Draft Report Reviewer/consultant with ECRI/Atheneum/QTC commercial services LLC/Connected Research and consulting/Vox.Bio.
Maria Elisa Samaniego, MD Dr. Samaniego has nothing to disclose.
Wei Yin Wei Yin has received personal compensation for serving as an employee of Takeda. Wei Yin has stock in Takeda.
Jennifer Anderson No disclosure on file
Jessica H. Fan, MD Dr. Fan has nothing to disclose.
Claudia M. Prospero Ponce, MD Dr. Prospero Ponce has nothing to disclose.
Teneille Gofton, MD The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
Shashwat Pokharel, MBBS Dr. Pokharel has nothing to disclose.
Saef Izzy, MD Dr. Izzy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus . The institution of Dr. Izzy has received research support from NINDS. The institution of Dr. Izzy has received research support from The Gillian Reny Stepping Strong Center for Trauma Innovation. Dr. Izzy has received publishing royalties from a publication relating to health care.
Walter G. Husar, MD Dr. Husar has nothing to disclose.
Karen Minnis Mrs. Minnis has received personal compensation for serving as an employee of Multiple Sclerosis Foundation.
Chi-Ying (Roy) Lin, MD, FAAN Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Piet C. De Groen, MD The institution of Prof. De Groen has received research support from Pfizer. The institution of Prof. De Groen has received research support from NIH. Prof. De Groen has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker at annual conference x2 with AAFPE. Prof. De Groen has received personal compensation in the range of $0-$499 for serving as a None with None.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Reid D. Taylor, MD Dr. Taylor has nothing to disclose.
Mohammad R. Ghani, MD Dr. Ghani has nothing to disclose.
Abdalhamid Lagnf, MD Dr. Lagnf has nothing to disclose.
Husam Al Sultani No disclosure on file
Hollie K. Schmidt Ms. Schmidt has received personal compensation for serving as an employee of Accelerated Cure Project for MS.
Kenneth Martiatu Mr. Martiatu has nothing to disclose.
Sheng-Han Kuo, MD Dr. Kuo has nothing to disclose.
Nicholas Belviso, PhD, PharmD Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Sanjay Anandaram, MD Dr. Anandaram has nothing to disclose.
Oleg Y. Chernyshev, MD, PhD, FAAN Dr. Chernyshev has nothing to disclose.
Andi Liang Miss Liang has nothing to disclose.
Samiksha Srivastava, MD Dr. Srivastava has nothing to disclose.
Kanika Sharma Ms. Sharma has nothing to disclose.
Mark Tarnopolsky, MD, PhD, FRCP Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care.
Adam M. Willis, MD The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Hironobu Endo, MD, PhD Dr. Endo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for APRINOIA Therapeutics. Dr. Endo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie Inc.. The institution of Dr. Endo has received research support from JSPS KAKENHI 21K15705.
Nirav R. Bhatt, MD Dr. Bhatt has nothing to disclose.
Robert J. Sharkus III, DO Dr. Sharkus has nothing to disclose.
Germán J. Medina-Rincón Mr. Medina-Rincón has nothing to disclose.
Ivan Bozin Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Maja Ostojic, DO Maja Ostojic has nothing to disclose.
Roberta Diaz Brinton, PhD Roberta Diaz Brinton, PhD has nothing to disclose.
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Jeremy Moeller, MD, FAAN Dr. Moeller has received publishing royalties from a publication relating to health care.
Larry Charleston IV, MD, MSc, FAHS Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Casey S. Albin, MD Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Instructor with Resuscitation Leadership Academy.
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Neelam Goyal, MD Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Lily J. Henson, MD, MMM, FAAN Dr. Henson has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms. An immediate family member of Dr. Henson has received publishing royalties from a publication relating to health care.
Cynthia E. Armand, MD Dr. Armand has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spire Learning. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Aaron L. Nelson, MD, FAAN Dr. Nelson has nothing to disclose.
Naila Kausar, MD Dr. Kausar has nothing to disclose.
Connor D. Welsh, DO Dr. Welsh has nothing to disclose.
Laura Borrega Canelo No disclosure on file
Helio Afonso G. Teive, MD Dr. Teive has nothing to disclose.
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Brian Moss Brian Moss has nothing to disclose.
Wendell R. Helveston, MD Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Helveston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Helveston has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BMS Pharmaceuticals. Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Helveston has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Helveston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Helveston has stock in Biogen. An immediate family member of Dr. Helveston has received personal compensation in the range of $500-$4,999 for serving as a Spokesperson with Lundbeck.
Mikael Guzman Karlsson, MD, PhD An immediate family member of Dr. Guzman Karlsson has received personal compensation for serving as an employee of Ventyx Biosciences, Inc..
Kenichiro Taira, MD, PhD Dr. Taira has nothing to disclose.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Annette Wundes, MD, FAAN The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Paola Valsasina No disclosure on file
Brandon P. Moss, MD An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Emily Weisbach, MD Dr. Weisbach has nothing to disclose.
Krutika Jariwala-Parikh, PhD Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
Sunita N. Misra, MD Dr. Misra has received personal compensation for serving as an employee of Neurelis, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Misra has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RubiconMD. Dr. Misra has received intellectual property interests from a discovery or technology relating to health care.
Gregory L. Branigan, PhD Dr. Branigan has nothing to disclose.
Aparna M. Prabhu, MD Dr. Prabhu has nothing to disclose.
Zahari Tchopev, MD Dr. Tchopev has nothing to disclose.
Satinderpal Singh, DO Dr. Singh has nothing to disclose.
Carmen Vizzino No disclosure on file
Maria Shoaib, MD Dr. Shoaib has nothing to disclose.
Seung-Ah Lee Miss Lee has nothing to disclose.
Sama Noroozi Gilandehi, MD Dr. Noroozi Gilandehi has nothing to disclose.
William A. Warren, MD Dr. Warren has nothing to disclose.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
Dustin J. Paul, DO Dr. Paul has nothing to disclose.
Joshua Kuluva, MD Dr. Kuluva has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Piedmont Neuroscience Center.
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech.
Angela Y. Peters, MD The institution of Dr. Peters has received research support from NIH.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Nitin V. Nadkarni, MD Dr. Nadkarni has nothing to disclose.
Patrick D. Gilson, DO Dr. Gilson has nothing to disclose.
Andre Granger, MD, MBA Dr. Granger has nothing to disclose.
Patrick O'Connor, MD Dr. O'Connor has nothing to disclose.
Sumin Kim, MD Dr. Kim has nothing to disclose.
Lisa Christopher-Stine, MD, MPH No disclosure on file
Courtney Venegas, MD Dr. Venegas has nothing to disclose.
Jo Ann Malatesta No disclosure on file
Maria Luisa Martinez Gines, MD Dr. Martinez Gines has nothing to disclose.
Carlos Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Video Panel with CNS Ratings LLC. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Course Organiztion with Omniprex Scientific Medical Eduaction. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Health Monitor Network. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Movement Disorders Society. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Workshop Moderator with International Neurotoxin Association Inc. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with CME Outfitteres LLC.
Caleene R. Goodis, APRN Mrs. Goodis has nothing to disclose.
Peter Hedera, MD Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Ana M. Alonso Torres, MD Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Melissa B. Pergakis, MD Dr. Pergakis has nothing to disclose.
Elham Askari, MD Dr. Askari has received personal compensation for serving as an employee of Stony Brook Hospital University.
Pannathat Soontrapa, MD The institution of Dr. Soontrapa has received research support from Argenx.
Kaitlin Schoder, NP Ms. Schoder has nothing to disclose.
Muthu Kuzhali Ganapathy, MBBS Dr. Ganapathy has nothing to disclose.
Ahmed El-Dokla, MD, FAAN Dr. El-Dokla has nothing to disclose.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Austin J. Priaulx Mr. Priaulx has nothing to disclose.
Muhammad I. Yousaf, MD Dr. Yousaf has nothing to disclose.
Eric Segal, MD Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Maria Jekielek, MD Dr. Jekielek has nothing to disclose.
Celeste Fine Ms. Fine has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Ms. Fine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Carolyn Black, MD, PhD Dr. Black has nothing to disclose.
Sally El Sammak, MD Dr. El Sammak has nothing to disclose.
Chandra C. Abbott, PhD Dr. Abbott has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Abbott has stock in Biohaven Pharmaceuticals, Inc..
Juan Pablo Cuello Juan Pablo Cuello has nothing to disclose.
Antonio Laurenza, MD Dr. Laurenza has received personal compensation for serving as an employee of Takeda. Dr. Laurenza has stock in Takeda.
Lydia Sobhi Ms. Sobhi has nothing to disclose.
Adrian Kielhorn Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
Sitara Koneru, MD Dr. Koneru has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES Dr. Mathias has nothing to disclose.
Shaweta Khosa, MD Dr. Khosa has nothing to disclose.
Tatjana Jarvis Miss Jarvis has nothing to disclose.
Sepideh Mokhtari, MD Dr. Mokhtari has nothing to disclose.
Giovanni Castellucci, MD, MS Dr. Castellucci has nothing to disclose.
Saif Huda, MD Dr. Huda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint.
Christopher P. Eckstein, MD The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme.
Kelsey R. Barrell, MD Dr. Juster-Switlyk has nothing to disclose.
Csaba Juhasz, MD The institution of Dr. Juhasz has received research support from NIH.
Jin Yun Helen Chen, MS, LCGC Ms. Chen has nothing to disclose.
Mario Bovino, MD Dr. Bovino has nothing to disclose.
Patrick M. Kwon, MD Dr. Kwon has nothing to disclose.
Isabella Sutherland Ms. Sutherland has nothing to disclose.
Robin L. Avila, PhD Mrs. Avila has received personal compensation for serving as an employee of Biogen. Mrs. Avila has stock in Biogen.
Nidhiben A. Anadani, MD Dr. Anadani has nothing to disclose.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Christopher Taylor, NP Mr. Taylor has nothing to disclose.
Julio Dotor Garcia-Soto JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Jesse Levine, MD, PhD Dr. Levine has nothing to disclose.
Anam K. Shaikh Miss Shaikh has nothing to disclose.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Ronald Zielman No disclosure on file
Seth N. Levin, MD Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Gabriela Romanow No disclosure on file
Nicholas R. Delcimmuto, MD Mr. Delcimmuto has nothing to disclose.
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Talita D'Aguiar Rosa, MD Dr. D'Aguiar Rosa has nothing to disclose.
Narjis Jaffry No disclosure on file
Carmen Calles, MD Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Raquel Farias-Moeller, MD Dr. Farias-Moeller has nothing to disclose.
Deborah Y. Bradshaw, MD, FAAN The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Valentine Jehl No disclosure on file
Marc H. Feinberg, MD Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eisai. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Feinberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Feinberg has stock in Amarin.
Alyssa Domingue, MD Dr. Domingue has nothing to disclose.
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Rachel Beekman, MD Dr. Beekman has nothing to disclose.
Samantha J. Tidd Mrs. Tidd has nothing to disclose.
Shannon Tierney, MD Dr. Tierney has nothing to disclose.
Rohit Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Maria P. Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Brian Harel, PhD Brian Harel has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel has stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel has stock in Eli Lilly, Pfizer, Astra Zeneca. Brian Harel has stock in Cogstate.
May Han, MD Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Mariana Suarez No disclosure on file
Catherine Boldig, DO Dr. Boldig has nothing to disclose.
Toshiyuki Yamamoto Dr. Yamamoto has nothing to disclose.
Yuhei Takado, MD Dr. Takado has nothing to disclose.
W. T. Longstreth, Jr., MD, FAAN The institution of Dr. Longstreth has received research support from NIH.
Yasmin Aghajan, MD Dr. Aghajan has nothing to disclose.
Elena Ratti, MD Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Matthias Dunse, MD Dr. Dunse has nothing to disclose.
Sofia Ramirez Guerrero Ms. Ramirez Guerrero has nothing to disclose.
Nora Wong No disclosure on file
Jesse Menville Ms. Menville has nothing to disclose.
Kee Duk Park, MD No disclosure on file
Tammy L. Smith, MD, PhD The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a attendee with Euroimmun Academy for travel support only.
Karan Philip, MBBS Dr. Philip has nothing to disclose.
Francisco Barrero-Hernandez No disclosure on file
Jose Manuel Garcia Dominguez Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Jose Manuel Garcia Dominguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall.
Tiffany Chen Tiffany Chen has nothing to disclose.
Subhan Khan, MD Dr. Khan has received personal compensation for serving as an employee of University of Kentucky.
John DeWitt No disclosure on file
Maggie Moran, MD Dr. Moran has nothing to disclose.
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
David M. Sletten, MBA Mr. Sletten has nothing to disclose.
Varun Kannan, MD Dr. Kannan has nothing to disclose.
Francisco Caiza Zambrano Mr. Caiza Zambrano has nothing to disclose.
Saman Zafar, MD Dr. Zafar has nothing to disclose.
Tamara Castillo-Trivino, MD, MAS, FAAN Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Sung-Hee Kim, MD Dr. Kim has nothing to disclose.
Jonathan Cauchi, MD Dr. Cauchi has nothing to disclose.
Adrian L. Rabinowicz, MD, FAAN Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.
Rachel Rodin, MD, PhD Dr. Rodin has nothing to disclose.
Danielle M. Andrade, MD Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zodiac. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke therapeutics. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities.
Christine Ochoa, MD Dr. Ochoa has nothing to disclose.
Emanuel Cassou, MD Dr. Cassou has nothing to disclose.
Brent Jacobus II, MD Dr. Jacobus has nothing to disclose.
Ji Y. Yun, MD Dr. Yun has nothing to disclose.
Luciano De Paola, MD No disclosure on file
Jennie P. Savage, MD Dr. Savage has nothing to disclose.
Sathvika Thermalingem, MBBS Dr. Thermalingem has nothing to disclose.
Cassie N. Chan, MD Dr. Chan has nothing to disclose.
Nicholas Thompson No disclosure on file
Nicolas Gaspard No disclosure on file
Avery Kundrick, MD Dr. Kundrick has nothing to disclose.
Ahmer Asif, MD Dr. Asif has nothing to disclose.
Matthew Hart, MD Dr. Hart has nothing to disclose.
Matt Makara No disclosure on file
Bassem I. Yamout, MD, FAAN Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Angela Applebee, MD Dr. Applebee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Applebee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Applebee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Applebee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Applebee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Applebee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Kathie Lin, MD Dr. Lin has nothing to disclose.
William Hoffman, MD The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Isaac Smith, DO, MS Dr. Smith has nothing to disclose.
William Beaty Mr. Beaty has nothing to disclose.
Carlos Roncero, PhD Dr. Roncero has nothing to disclose.
Jesus Manuel Martin Martinez Jesus Manuel Martin Martinez has nothing to disclose.
Evan Fields, MD Dr. Fields has nothing to disclose.
Max J. Hilz, MD, PhD, FAAN Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Danwei Wu, MD Dr. Wu has nothing to disclose.
Subin Mathew, MD Dr. Mathew has nothing to disclose.
Hyunji Kim Ms. Kim has nothing to disclose.
Pratibha Surathi, MD Dr. Surathi has nothing to disclose.
Benjamin J. Osborne, MD, FAAN Dr. Osborne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.
Daniel Brooks, MD No disclosure on file
Jurriaan Peters, MD Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Ismail M. Fahad, MBBS Dr. Fahad has nothing to disclose.
Yahaira Rivera Bobadilla No disclosure on file
Aimee Luat, MD Dr. Luat has nothing to disclose.
Durjoy Lahiri, MD, DM Dr. Lahiri has nothing to disclose.
Madoka Mori-Yoshimura, MD, PhD Dr. Mori-Yoshimura has nothing to disclose.
Julien Cavanagh, MD Dr. Cavanagh has nothing to disclose.
Jordan G. Gates, DO Dr. Gates has nothing to disclose.
Sandra Vukusic, MD The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Henssey Ngo, MD Dr. Ngo has nothing to disclose.
Ermal Aliu No disclosure on file
Mered Parnes, MD Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Parnes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. The institution of Dr. Parnes has received research support from NIH. The institution of Dr. Parnes has received research support from Alexion.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Sarah England, PhD Dr. England has received personal compensation for serving as an employee of Biogen. Dr. England has stock in Biogen.
Sharon Stoll, DO Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Alexandra Rubenstein Miss Rubenstein has nothing to disclose.
Mohsen Ahmed Mr. Ahmed has nothing to disclose.
Natalie Blake Natalie Blake has received personal compensation for serving as an employee of Multiple Sclerosis Foundation, Inc..
Young-Chul Choi Young-Chul Choi has nothing to disclose.
Octavio Arevalo No disclosure on file
Rocío Gómez, Other Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Kunal V. Desai, MD Dr. Desai has nothing to disclose.
Myla D. Goldman, MD, MSC, FAAN Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Seronon. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, IDEC. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADAMAS. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., .
Robert Kadish, MD Dr. Kadish has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Kadish has received research support from Alexion Pharmaceuticals.
Erin Barnes, MD Dr. Barnes has nothing to disclose.
Richa M. Thakkar, DO Dr. Thakkar has nothing to disclose.
Gary D. Clark, MD The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
Ulf Schulze Topphoff Ulf Schulze Topphoff has received personal compensation for serving as an employee of Novartis Pharma GmbH.
Anna Shah, MD The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Shah has received personal compensation in the range of $5,000-$9,999 for serving as a Educational Speaker with Rocky Mountain MS Center.
Melissa M. Cortez, DO The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Cynthia Wong No disclosure on file
Ziqi Wang Mr. Wang has nothing to disclose.
Alissa A. Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Luciana V. Leon Cejas, MD Dr. Leon Cejas has nothing to disclose.
Kathleen B. Mullin, MD Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Clara Tierney, MD Dr. Tierney has nothing to disclose.
Andrew N. Ameri, MD Dr. Ameri has nothing to disclose.
Aditya Shah Mr. Shah has nothing to disclose.
Amparo Gutierrez, MD, FAAN Dr. Gutierrez has nothing to disclose.
Jessie Iregui Miss Iregui has nothing to disclose.
Melissa A. Wright, MD Dr. Wright has nothing to disclose.
Anu Jacob, MD Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Thomas E. Lloyd, MD, PhD Dr. Lloyd has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Allison J. Chirigos, MD Dr. Chirigos has nothing to disclose.
Suma Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Annette Okai, MD, FAAN Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD SERONO . Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme .
Serdar Kazanci, MD Dr. Kazanci has nothing to disclose.
Atef Kokash, DO Dr. Kokash has nothing to disclose.
Tonette Gehrking Tonette Gehrking has nothing to disclose.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Grace Crotty, MD The institution of Dr. Crotty has received research support from Parkinson's Foundation. The institution of Dr. Crotty has received research support from American Academy of Neurology.
Nicholas D. Lawn, FRACP, MBCHB Dr. Lawn has nothing to disclose.
Rajesh K. Gupta, MBBS Dr. Gupta has nothing to disclose.
Jay D. Varrato, DO Dr. Varrato has nothing to disclose.
Jonathan M. Yarimi, MD Dr. Yarimi has nothing to disclose.
Rosario Blasco Quilez Rosario Blasco Quilez has nothing to disclose.
Amitha Ananth, MD Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.
Jennifer Lord, MD Dr. Lord has nothing to disclose.
Sara E. Hocker, MD, FAAN The institution of Dr. Hocker has received research support from Yale University. Dr. Hocker has received publishing royalties from a publication relating to health care.
Mariona Hervas Pujol Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Joseph Zachariah, DO Dr. Zachariah has nothing to disclose.
Carlos Garcia Rodriguez, MD Dr. Garcia Rodriguez has nothing to disclose.
Bhagyashri U. Bhende, MBBS Dr. Bhende has nothing to disclose.
Mirasol Forcadela, MD Dr. Forcadela has nothing to disclose.
Betsy Ostrander, MD Dr. Ostrander has nothing to disclose.
Christian Amlang, MD Dr. Amlang has nothing to disclose.
Ashmeet S. Sahni, MD Dr. Sahni has nothing to disclose.
Jade Gehrking Jade Gehrking has nothing to disclose.
Kaitlyn Hay No disclosure on file
Gabriela A. Bou, MD Dr. Bou has nothing to disclose.
Ravi Chilukuri, MD Dr. Chilukuri has nothing to disclose.
Vera J. Burton, MD, PhD Dr. Burton has nothing to disclose.
Christine Meadows, MD Dr. Meadows has nothing to disclose.
Jason B. Richards, MD The institution of Dr. Richards has received research support from Brown Physicians, Inc.
David J. Houghton, MD Dr. Houghton has nothing to disclose.
Pritikanta Paul, MD Dr. Paul has nothing to disclose.
Ichizo Nishino, MD, PhD, FAAN The institution of Dr. Nishino has received research support from AMED.
Matthew Scaramozza Mr. Scaramozza has received personal compensation for serving as an employee of Biogen. Mr. Scaramozza has stock in Biogen. Mr. Scaramozza has received intellectual property interests from a discovery or technology relating to health care.
Daod Pak, MD Dr. Pak has nothing to disclose.
Umair Azhar Mr. Azhar has nothing to disclose.
Noor Mahmoud, MD Dr. Mahmoud has nothing to disclose.
Sibi Thirunavukkarasu, MD Dr. Thirunavukkarasu has nothing to disclose.
Mariam Hull, MD Dr. Hull has received publishing royalties from a publication relating to health care.
Sviatoslav Redko, MD Dr. Redko has nothing to disclose.
Michael McAree, DO Dr. McAree has nothing to disclose.
Arthur Simen Arthur Simen has received personal compensation for serving as an employee of Takeda.
Soroush Kakawand, MD Dr. Kakawand has nothing to disclose.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Sania Azhar Ms. Azhar has nothing to disclose.
Benjamin Cho No disclosure on file
David A. Stamler, MD Dr. Stamler has received personal compensation for serving as an employee of Alterity Therapeutics. Dr. Stamler has stock in Alterity Therapeutics.
Amy Wynn, NP Ms. Wynn has nothing to disclose.
Casey Engel Casey Engel has nothing to disclose.
Konstantinos Tourlas, MD Dr. Tourlas has stock in Axonics Modulation Technologies (AXNX). Dr. Tourlas has stock in Biote (BTMD).
Stephanie Lyden, MD Dr. Lyden has nothing to disclose.
John M. Mason, DO Dr. Mason has nothing to disclose.
Sarah Lee, MD Dr. Lee has nothing to disclose.
Nicholas A. Morris, MD, FAAN The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $0-$499 for serving as a Grand Rounds Speaker with New York University. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Speaker with Mount Sinai Health System. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Continuum Article Author with American Academy of Neurology. Dr. Morris has received personal compensation in the range of $0-$499 for serving as a Reviewer with Society of Critical Care Medicine. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Speaker with New York Medical College. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics.
Sarah G. Engel, MD Dr. Engel has nothing to disclose.
Jose Luis Sanchez Menoyo, MD Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Kinyee Fong No disclosure on file
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Mattia Wruble, MD Dr. Wruble has nothing to disclose.
Aditi V. Varma-Doyle, MD Dr. Varma-Doyle has nothing to disclose.
Shane Poole No disclosure on file
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Arielle Davis, MD Dr. Davis has nothing to disclose.
Chelsea Schmoll, DO Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Schmoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Salman Rashid, MD Dr. Rashid has nothing to disclose.
Laura Cacciaguerra, MD, PhD Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Cacciaguerra has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOMEDIA.
Chiseko Ikenaga, MD, PhD Dr. Ikenaga has nothing to disclose.
Jaya R. Trivedi, MD, FAAN Dr. Trivedi has nothing to disclose.
Katherine Hammitt No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brian L. Johnson, MD Dr. Johnson has nothing to disclose.
Irena Dujmovic Basuroski, MD, PhD The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund.
Karnig Kazazian Mr. Kazazian has nothing to disclose.
Kyle Mahoney, MD The institution of Dr. Mahoney has received research support from Viela Bio.
Eric Stulberg, MD Dr. Stulberg has nothing to disclose.
Roseanne Sullivan Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Kristen L. Veal Dr. Veal has nothing to disclose.
Laura Navarro Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
William D. Schnapp, MD Dr. Schnapp has received intellectual property interests from a discovery or technology relating to health care.
Ping Shi, MD Dr. Shi has nothing to disclose.
Tamanna Singh No disclosure on file
Idelle V. Aschen, MD Dr. Aschen has nothing to disclose.
Hassan Souidan, MD Dr. Souidan has nothing to disclose.
Matthew Feldman, MD Dr. Feldman has nothing to disclose.
Sankalp V. Bhavsar, MD Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Bhavsar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bhavsar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis.
Kristin Moy No disclosure on file
Richard M. Gustin, PhD Dr. Gustin has received personal compensation for serving as an employee of Neurelis. Dr. Gustin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for The Recovery Research Network Foundation.
Evan Huff, MD Mr. Huff has nothing to disclose.
Aliya Shabbir Ms. Shabbir has nothing to disclose.
Micaela Forshaw Micaela Forshaw has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Micaela Forshaw has received stock or an ownership interest from Biohaven Pharmaceuticals.
James Liao, MD The institution of Dr. Liao has received research support from American Parkinson Disease Association.
Luke Heyliger, MD Dr. Heyliger has nothing to disclose.
Eduardo Aguera Morales, MD, PhD Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Larissa Maria F. Faria Miss Faria has nothing to disclose.
Linda Mosher No disclosure on file
Robert G. Wilson, DO Dr. Wilson has nothing to disclose.
Maegan Newell, MD Dr. Newell has nothing to disclose.
Debolina Ghosh Miss Ghosh has nothing to disclose.
Bhavya Narapureddy, MBBS Dr. Narapureddy has nothing to disclose.
Samer Kebbeh, MD Dr. Kebbeh has nothing to disclose.
Jason MacMore Jason MacMore has nothing to disclose.
Ronak U. Trivedi Mr. Trivedi has nothing to disclose.
Elijah Lackey, MD Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity.
Anoopum Gupta, MD, PhD Dr. Gupta has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biogen. The institution of Dr. Gupta has received research support from Biogen.
Michael R. Sperling, MD, FAAN Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Ruo-Yah Lai Ms. Lai has nothing to disclose.
Sanjay G. Ramteke, MD Dr. Ramteke has nothing to disclose.
Luis Brieva Ruiz, MD Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Sayyeda Zahra, MD Dr. Zahra has nothing to disclose.
Rajinder Bhardwaj No disclosure on file
Ioana Medrea, MD Dr. Medrea has nothing to disclose.
Paul D. Crane, MD Dr. Crane has nothing to disclose.
Muhammed Ors Mr. Ors has nothing to disclose.
Shivang Joshi, MD Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Currax. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Relivion. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nerivio. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axiome. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Joshi has received research support from Lilly . The institution of Dr. Joshi has received research support from Biohaven. The institution of Dr. Joshi has received research support from Amgen.
Shauna Cheung, MD Dr. Cheung has nothing to disclose.
Irene Chu, MD Dr. Chu has nothing to disclose.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Jaya Padmanabhan Jaya Padmanabhan has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Jaya Padmanabhan has stock in Takeda Pharmaceuticals.
Stefanie J. Rodenbeck, MD Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Nadia Azad Ms. Azad has nothing to disclose.
Christina N. Fournier, MD Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roon. Dr. Fournier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for QurAlis. Dr. Fournier has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Journals. The institution of Dr. Fournier has received research support from Veterans Affairs. The institution of Dr. Fournier has received research support from Department of Defense. The institution of Dr. Fournier has received research support from Amylyx. The institution of Dr. Fournier has received research support from Biogen. The institution of Dr. Fournier has received research support from MT Pharma. The institution of Dr. Fournier has received research support from Columbia University. The institution of Dr. Fournier has received research support from Denali.
William R. Tyor, MD, FAAN The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Andrew Tarr, MD Dr. Tarr has nothing to disclose.
Javier Sotoca Fernandez No disclosure on file
Galina Gheihman, MD Dr. Gheihman has nothing to disclose.
Danielle M. Howard, MD The institution of Dr. Howard has received research support from Genentech. The institution of Dr. Howard has received research support from Novartis. Dr. Howard has received personal compensation in the range of $50,000-$99,999 for serving as a Clinical Fellow with National Multiple Sclerosis Society.
Tamara B. Kaplan, MD Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono .
George K. Harrold, MD Dr. Harrold has nothing to disclose.
Robert Freundlich, MD Dr. Freundlich has nothing to disclose.
Iqra Faiz Miss Faiz has nothing to disclose.
David Semel David Semel has received personal compensation for serving as an employee of pfizer.
Jing Liu Jing Liu has received personal compensation for serving as an employee of Pfizer, Inc.. Jing Liu has stock in Pfizer, Inc. .